Bridgecreek Investment Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-7,215
| Closed | -$239K | – | 100 |
|
|
2023
Q3 | $239K | Sell |
7,215
-500
| -6% | -$17.7K | 0.05% | 87 |
|
|
2023
Q2 | $283K | Hold |
7,715
| – | – | 0.05% | 84 |
|
|
2023
Q1 | $315K | Hold |
7,715
| – | – | 0.06% | 80 |
|
|
2022
Q4 | $395K | Buy |
7,715
+1,050
| +16% | +$50.3K | 0.09% | 81 |
|
|
2022
Q3 | $292K | Hold |
6,665
| – | – | 0.06% | 96 |
|
|
2022
Q2 | $349K | Sell |
6,665
-19,500
| -75% | -$994K | 0.07% | 90 |
|
|
2022
Q1 | $1.35M | Buy |
26,165
+847
| +3% | +$43.9K | 0.2% | 71 |
|
|
2021
Q4 | $1.5M | Sell |
25,318
-2,500
| -9% | -$124K | 0.2% | 68 |
|
|
2021
Q3 | $1.2M | Hold |
27,818
| – | – | 0.17% | 71 |
|
|
2021
Q2 | $1.09M | Sell |
27,818
-497
| -2% | -$19.3K | 0.16% | 70 |
|
|
2021
Q1 | $1.03M | Hold |
28,315
| – | – | 0.16% | 64 |
|
|
2020
Q4 | $1.04M | Sell |
28,315
-1,303
| -4% | -$47.8K | 0.16% | 64 |
|
|
2020
Q3 | $1.03M | Buy |
29,618
+527
| +2% | +$18.5K | 0.18% | 61 |
|
|
2020
Q2 | $903K | Hold |
29,091
| – | – | 0.17% | 61 |
|
|
2020
Q1 | $901K | Buy |
29,091
+527
| +2% | +$18K | 0.23% | 53 |
|
|
2019
Q4 | $1.06M | Sell |
28,564
-8,778
| -24% | -$313K | 0.19% | 69 |
|
|
2019
Q3 | $1.27M | Hold |
37,342
| – | – | 0.26% | 66 |
|
|
2019
Q2 | $1.53M | Hold |
37,342
| – | – | 0.32% | 63 |
|
|
2019
Q1 | $1.5M | Hold |
37,342
| – | – | 0.32% | 69 |
|
|
2018
Q4 | $1.55M | Hold |
37,342
| – | – | 0.41% | 59 |
|
|
2018
Q3 | $1.56M | Hold |
37,342
| – | – | 0.31% | 67 |
|
|
2018
Q2 | $1.28M | Hold |
37,342
| – | – | 0.28% | 70 |
|
|
2018
Q1 | $1.26M | Hold |
37,342
| – | – | 0.28% | 72 |
|
|
2017
Q4 | $1.28M | Sell |
37,342
-4,480
| -11% | -$153K | 0.3% | 70 |
|
|
2017
Q3 | $1.42M | Sell |
41,822
-3,126
| -7% | -$100K | 0.38% | 65 |
|
|
2017
Q2 | $1.43M | Hold |
44,948
| – | – | 0.38% | 67 |
|
|
2017
Q1 | $1.46M | Hold |
44,948
| – | – | 0.4% | 68 |
|
|
2016
Q4 | $1.39M | Sell |
44,948
-474
| -1% | -$14.5K | 0.39% | 68 |
|
|
2016
Q3 | $1.46M | Buy |
45,422
+3,689
| +9% | +$123K | 0.44% | 63 |
|
|
2016
Q2 | $1.39M | Buy |
41,733
+527
| +1% | +$16.8K | 0.43% | 63 |
|
|
2016
Q1 | $1.16M | Buy |
41,206
+1,054
| +3% | +$30.1K | 0.37% | 65 |
|
|
2015
Q4 | $1.23M | Sell |
40,152
-1,054
| -3% | -$33.2K | 0.39% | 61 |
|
|
2015
Q3 | $1.23M | Hold |
41,206
| – | – | 0.37% | 64 |
|
|
2015
Q2 | $1.31M | Hold |
41,206
| – | – | 0.33% | 73 |
|
|
2015
Q1 | $1.36M | Hold |
41,206
| – | – | 0.32% | 74 |
|
|
2014
Q4 | $1.22M | Buy |
41,206
+2,108
| +5% | +$60.4K | 0.32% | 66 |
|
|
2014
Q3 | $1.1M | Hold |
39,098
| – | – | 0.29% | 67 |
|
|
2014
Q2 | $1.1M | Hold |
39,098
| – | – | 0.29% | 70 |
|
|
2014
Q1 | $1.19M | Sell |
39,098
-270
| -0.7% | -$8.05K | 0.35% | 68 |
|
|
2013
Q4 | $1.14M | Buy |
39,368
+270
| +0.7% | +$7.86K | 0.35% | 63 |
|
|
2013
Q3 | $1.07M | Hold |
39,098
| – | – | 0.31% | 69 |
|
|
2013
Q2 | $1.04M | Buy |
+39,098
| New | +$1.08M | 0.35% | 58 |
|
Other funds holding PFE
Bridgecreek Investment Management's PFE Position: Q4 2023 in Review
Bridgecreek Investment Management sold out of Pfizer (PFE) in Q4 2023, closing a stake of 7,215 shares — an estimated $239K sold.
Bridgecreek Investment Management first reported a position in PFE in Q2 2013 and held it in 42 quarters. The position peaked at $1.56M in Q3 2018. 2,936 funds tracked by Wall St. Rank hold PFE as of Q4 2023.
- Bridgecreek Investment Management reported no remaining Pfizer position as of Q4 2023 after selling out during the quarter.
- Bridgecreek Investment Management sold 7,215 Pfizer shares in Q4 2023, an estimated $239K.
- Bridgecreek Investment Management first reported a position in Pfizer in Q2 2013 and held it in 42 quarters.
- Bridgecreek Investment Management's Pfizer position peaked at $1.56M in Q3 2018.
- 2,936 funds tracked by Wall St. Rank held Pfizer as of Q4 2023.
Based on Bridgecreek Investment Management's 13F filing for Q4 2023, filed 13 Feb 2024.